{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T11:54:31Z","timestamp":1721994871329},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/mjt.0000000000000095","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T12:46:05Z","timestamp":1402404365000},"page":"e558-e560","source":"Crossref","is-referenced-by-count":7,"title":["Fanconi Syndrome and Antiretrovirals"],"prefix":"10.1097","volume":"23","author":[{"given":"Faraz Khan","family":"Luni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdur Rahman","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohini","family":"Prashar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Vetteth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan M.","family":"Duggan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-27-20210202","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1086\/378068","article-title":"Tenofovir disoproxil fumarate.","volume":"37","author":"Gallant","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R3-27-20210202","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1097\/QAD.0b013e3280b07b33","article-title":". The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years.","volume":"21","author":"Nelson","year":"2007","journal-title":"AIDS"},{"key":"R4-27-20210202","doi-asserted-by":"crossref","first-page":"E61","DOI":"10.1016\/j.jinf.2004.08.031","article-title":"Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatmentcase report and review of literature.","volume":"51","author":"Malik","year":"2005","journal-title":"J Infect"},{"key":"R5-27-20210202","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/ajkd.2003.50037","article-title":". Drug-induced Fanconis syndrome.","volume":"41","author":"Izzedine","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R6-27-20210202","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1053\/j.ajkd.2006.08.009","article-title":"Aminoglycoside-associated Fanconi syndrome.","volume":"48","author":"Ghiculescu","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"R7-27-20210202","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/hupa.2001.25586","article-title":". Adefovir nephrotoxicity: possible role of mitochondrial DNA depletion.","volume":"32","author":"Tanji","year":"2001","journal-title":"Hum Pathol"},{"key":"R8-27-20210202","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ndt\/17.1.148","article-title":". Cidofovir-induced end-stage renal failure.","volume":"17","author":"Meier","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"R9-27-20210202","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1124\/mol.56.3.570","article-title":". The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1.","volume":"56","author":"Cihlar","year":"1999","journal-title":"Mol Pharmacol"},{"key":"R10-27-20210202","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1124\/mol.106.028233","article-title":". Functional involvement of multidrug resistance-associated protein 4 (MRP4ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir.","volume":"71","author":"Imaoka","year":"2007","journal-title":"Mol Pharmacol"},{"key":"R11-27-20210202","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.ackd.2009.07.009","article-title":"Antiretroviral medications: adverse effects on the kidney.","volume":"17","author":"Jao","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"R12-27-20210202","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1128\/AAC.48.5.1469-1487.2004","article-title":". Biological effects of short-term or prolonged administration of 9-2-(phosphonomethoxy) propyl adenine (tenofovir) to newborn and infant rhesus macaques.","volume":"48","author":"Van Rompay","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"R13-27-20210202","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0166-3542(03)00005-6","article-title":". Evaluation of mitochondrial DNA content and enzyme levels in tenofovir DF-treated rats, rhesus monkeys and woodchucks.","volume":"58","author":"Biesecker","year":"2003","journal-title":"Antiviral Res"},{"key":"R14-27-20210202","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":". Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial.","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"R15-27-20210202","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1730-1270(10)60082-3","article-title":"Mikula T, et al..","volume":"8","author":"Winiarczyk","year":"2009","journal-title":"Nephrotoxicity of Tenofovir true or myth HIV AIDS Rev"},{"key":"R16-27-20210202","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1086\/499048","article-title":". Tenofovir-associated acute and chronic kidney disease: a case of multiple drug interactions.","volume":"42","author":"Zimmermann","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R17-27-20210202","first-page":"114","article-title":". Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.","volume":"19","author":"Irizarry-Alvarado","year":"2009","journal-title":"AIDS Read"},{"key":"R18-27-20210202","doi-asserted-by":"crossref","first-page":"e174","DOI":"10.1086\/379829","article-title":". Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine.","volume":"37","author":"Rollot","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0000000000000095","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:24:43Z","timestamp":1620962683000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201603000-00027"}},"subtitle":["It Is Never Too Late"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0000000000000095","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}